Skip to Main Content

Author Details

Michael J Crowther
8University of Leicester
2012
51
23
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37038100Exploring different research questions via complex multi-state models when using registry-based repeated prescriptions of antidepressants in women with breast cancer and a matched population comparison group.BMC Med Res Methodol2023
35044255Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network.Stat Methods Med Res2022
33469974Multiple imputation strategies for a bounded outcome variable in a competing risks analysis.Stat Med2021
33710334Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival.Blood Adv2021
33813933Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial-Based Cost-Effectiveness Data.Med Decis Making2021
33556998A multistate model incorporating estimation of excess hazards and multiple time scales.Stat Med2021
35079747INTEREST: INteractive Tool for Exploring REsults from Simulation sTudies.J Data Sci Stat Vis2021
34837946Development of a dynamic interactive web tool to enhance understanding of multi-state model analyses: MSMplus.BMC Med Res Methodol2021
34006026Assessing relative COVID-19 mortality: a Swiss population-based study.BMJ Open2021
33430778Relaxing the assumption of constant transition rates in a multi-state model in hospital epidemiology.BMC Med Res Methodol2021
32426746Assessing the Course of Organ Dysfunction Using Joint Longitudinal and Time-to-Event Modeling in the Vasopressin and Septic Shock Trial.Crit Care Explor2020
31894164Mixed-effects models for health care longitudinal data with an informative visiting process: A Monte Carlo simulation study.Stat Neerl2020
32073229Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective study.J Thromb Haemost2020
32165717Jointly modelling longitudinally measured urinary human chorionic gonadotrophin and early pregnancy outcomes.Sci Rep2020
30499863Changes in Body Mass Index and Rates of Death and Transplant in Hemodialysis Patients: A Latent Class Joint Modeling Approach.Epidemiology2019
31328285Impact of model misspecification in shared frailty survival models.Stat Med2019
30378472Joint longitudinal and time-to-event models for multilevel hierarchical data.Stat Methods Med Res2019
30652356Using simulation studies to evaluate statistical methods.Stat Med2019
30562050Donor Lung Sequence Number and Survival after Lung Transplantation in the United States.Ann Am Thorac Soc2019
30664613Measuring and Analyzing Length of Stay in Critical Care Trials.Med Care2019
27114326Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.Stat Methods Med Res2018
29701996An Alternative Approach for the Analysis of Time-to-Event and Survival Outcomes in Pulmonary Medicine.Am J Respir Crit Care Med2018
29020167Adjusting Expected Mortality Rates Using Information From a Control Population: An Example Using Socioeconomic Status.Am J Epidemiol2018
25416688Adjusting for treatment switching in randomised controlled trials - A simulation study and a simplified two-stage method.Stat Methods Med Res2017
28353690Impact of Rates of Change of Lamina Cribrosa and Optic Nerve Head Surface Depths on Visual Field Progression in Glaucoma.Invest Ophthalmol Vis Sci2017
28851772Determining the sample size required to establish whether a medical device is non-inferior to an external benchmark.BMJ Open2017
28872690Parametric multistate survival models: Flexible modelling allowing transition-specific distributions with application to estimating clinically useful measures of effect differences.Stat Med2017
28633324Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.Am J Epidemiol2017
27910122One-stage individual participant data meta-analysis models: estimation of treatment-covariate interactions must avoid ecological bias by separating out within-trial and across-trial information.Stat Med2017
28008649Flexible parametric modelling of the cause-specific cumulative incidence function.Stat Med2017
27629911Analysis of urinary human chorionic gonadotrophin concentrations in normal and failing pregnancies using longitudinal, Cox proportional hazards and two-stage modelling.Ann Clin Biochem2017
26864674Using electronic health records to predict costs and outcomes in stable coronary artery disease.Heart2016
26514596Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification.Stat Med2016
27042338Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER).Eur Heart J Qual Care Clin Outcomes2016
27027882Joint longitudinal hurdle and time-to-event models: an application related to viral load and duration of the first treatment regimen in patients with HIV initiating therapy.Stat Med2016
24634327Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.Stat Med2015
26434359Reply to Letter to the Editor by Remontet et al.Stat Med2015
26032839Responses to discussants of 'Joint modeling of survival and longitudinal non-survival data: current methods and issues. report of the DIA Bayesian joint modeling working group'.Stat Med2015
25634033Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.Health Technol Assess2015
25752749Setting benchmark revision rates for total hip replacement: analysis of registry evidence.BMJ2015
24449433Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendations.Med Decis Making2014
25220693A general framework for parametric survival analysis.Stat Med2014
24789760Multilevel mixed effects parametric survival models using adaptive Gauss-Hermite quadrature with application to recurrent events and individual participant data meta-analysis.Stat Med2014
23613458Simulating biologically plausible complex survival data.Stat Med2013
26053655Using meta-analysis to inform the design of subsequent studies of diagnostic test accuracy.Res Synth Methods2013
24289257Adjusting for measurement error in baseline prognostic biomarkers included in a time-to-event analysis: a joint modelling approach.BMC Med Res Methodol2013
22340890What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.Health Technol Assess2012
22555396Should relative survival be used with lung cancer data?Br J Cancer2012
22443286Individual patient data meta-analysis of survival data using Poisson regression models.BMC Med Res Methodol2012
23037571Flexible parametric joint modelling of longitudinal and survival data.Stat Med2012
  • 1 - 50 of 51

Recommended Authors

Duke-NUS Medical School, National University of Singapore
Career Start Year 2016
Number of shared co-authors 0
University of Texas Southwestern Medical Center.
Career Start Year 2013
Number of shared co-authors 0
School of Medicine Case Western Reserve University Cleveland OH USA.
Career Start Year 2011
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2011
Number of shared co-authors 0
Janssen Pharmaceutical Research and Development
Career Start Year 2010
Number of shared co-authors 0
Feinberg School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Georgetown University
Career Start Year 2008
Number of shared co-authors 0
Center for Biostatistics, Icahn School of Medicine at Mount Sinai
Career Start Year 2006
Number of shared co-authors 0
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2005
Number of shared co-authors 0
Perelman School of Medicine, The University of Pennsylvania
Career Start Year 2005
Number of shared co-authors 3
Ralph H. Johnson Veterans Affairs Healthcare System.
Career Start Year 2004
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 2004
Number of shared co-authors 0
University of North Carolina
Career Start Year 2004
Number of shared co-authors 1
Hospital of the University of Pennsylvania
Career Start Year 2003
Number of shared co-authors 0
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
and Informatics Perelman School of Medicine, University of Pennsylvania
Career Start Year 2003
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 1
University of Oxford
Career Start Year 2002
Number of shared co-authors 1
Stanford University
Career Start Year 2001
Number of shared co-authors 0
University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 1999
Number of shared co-authors 0
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Trecht University
Career Start Year 1997
Number of shared co-authors 0
Stanford University
Career Start Year 1997
Number of shared co-authors 1
Erasmus Medical Center
Career Start Year 1996
Number of shared co-authors 4
University of Pennsylvania Perelman School of Medicine
Career Start Year 1995
Number of shared co-authors 2
University Health Network
Career Start Year 1994
Number of shared co-authors 1
Leiden University Medical Center
Career Start Year 1992
Number of shared co-authors 0
University of Washington
Career Start Year 1992
Number of shared co-authors 1
Harvard Medical School
Career Start Year 1988
Number of shared co-authors 2
New York University.
Career Start Year 1987
Number of shared co-authors 0

Collaborators

University of Pennsylvania, Perelman School of Medicine
Co-authored papers 4
Karolinska Institutet
Co-authored papers 4
University of Virginia
Co-authored papers 2
University of Pennsylvania Perelman School of Medicine
Co-authored papers 2
Co-authored papers 2
University of North Carolina
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
The University of Hong Kong
Co-authored papers 1
St. Paul's Hospital, University of British Columbia
Co-authored papers 1
Co-authored papers 1
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
University of New South Wales
Co-authored papers 1
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
Boston University School of Medicine
Co-authored papers 1
University of Pennsylvania
Co-authored papers 1